Cite
HARVARD Citation
Elli, E. et al. (2022). Deferasirox in the management of iron overload in patients with myelofibrosis treated with ruxolitinib: The multicentre retrospective RUX‐IOL study. British journal of haematology. pp. 190-200. [Online].